Literature DB >> 12648697

Inguinofemoral dissection for carcinoma of the vulva: effect of modifications of extent and technique on morbidity and survival.

Roman Rouzier1, Bassam Haddad, Gil Dubernard, Philippe Dubois, Bernard-Jean Paniel.   

Abstract

BACKGROUND: The aim of this study was to evaluate the impact of modifications of extent (medial inguinal and medial femoral lymphadenectomy, inguinal lymphadenectomy, inguinal and medial femoral lymphadenectomy, and inguinofemoral lymphadenectomy) and surgical technique of lymphadenectomy (including sartorius transposition, preservation of the fascia lata, and preservation of the saphenous vein) on morbidity, groin recurrence, and survival in patients with vulvar carcinoma. STUDY
DESIGN: A retrospective review of 194 patients with primary squamous cell cancer of the vulva was conducted. Clinical, surgical, histopathologic, postoperative short- and longterm complications, and followup data were collected from patient records.
RESULTS: Inguinal lymphadenectomy and medial inguinal and medial femoral lymphadenectomy produced about half fewer nodes than did other surgical procedures. On the other hand, number of lymph nodes removed did not differ notably between inguinofemoral lymphadenectomy and inguinal and medial femoral lymphadenectomy. Logistic regression showed that obesity was associated with increased risk of cellulitis. Age greater than 70, obesity, and extent of lymphadenectomy increased wound breakdown risk. Factors associated with leg edema persisting for more than 6 months were: extent of lymphadenectomy, sartorius transposition, and adjuvant irradiation of groin area. With a mean followup time of 38 months, neither groin recurrence rate nor disease-specific survival markedly differed according to technique of lymphadenectomy.
CONCLUSION: Techniques of lymphadenectomy with preservation of fascia lata and saphenous vein are associated with a decreased risk of postoperative morbidity without jeopardizing outcomes. Copyright 2003 by the American College of Surgeons

Entities:  

Mesh:

Year:  2003        PMID: 12648697     DOI: 10.1016/S1072-7515(02)01895-1

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  27 in total

1.  Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients.

Authors:  Sharon B Chang; Robert L Askew; Yan Xing; Storm Weaver; Jeffrey E Gershenwald; Jeffrey E Lee; Richard Royal; Anthony Lucci; Merrick I Ross; Janice N Cormier
Journal:  Ann Surg Oncol       Date:  2010-03-25       Impact factor: 5.344

Review 2.  Management of lymph nodes in the treatment of vulvar cancer.

Authors:  Toshiaki Saito; Keiji Kato
Journal:  Int J Clin Oncol       Date:  2007-06-27       Impact factor: 3.402

3.  Effectiveness of intraoperative indocyanine-green fluorescence angiography during inguinal lymph node dissection for skin cancer to prevent postoperative wound dehiscence.

Authors:  Hiroshi Furukawa; Toshihiko Hayashi; Akihiko Oyama; Emi Funayama; Naoki Murao; Takeshi Yamao; Yuhei Yamamoto
Journal:  Surg Today       Date:  2014-07-26       Impact factor: 2.549

4.  Weight lifting in patients with lower-extremity lymphedema secondary to cancer: a pilot and feasibility study.

Authors:  Elana Katz; Nicole L Dugan; Joy C Cohn; Christina Chu; Rebecca G Smith; Kathryn H Schmitz
Journal:  Arch Phys Med Rehabil       Date:  2010-07       Impact factor: 3.966

Review 5.  Update on sentinel lymph node evaluation in gynecologic malignancies.

Authors:  Katina Robison; Laura L Holman; Richard G Moore
Journal:  Curr Opin Obstet Gynecol       Date:  2011-02       Impact factor: 1.927

6.  Evolution and outcomes of sentinel lymph node mapping in vulvar cancer.

Authors:  Vance Broach; Nadeem R Abu-Rustum; Yukio Sonoda; Carol L Brown; Elizabeth Jewell; Ginger Gardner; Dennis S Chi; Oliver Zivanovic; Mario M Leitao
Journal:  Int J Gynecol Cancer       Date:  2020-02-18       Impact factor: 3.437

7.  Cost-effectiveness analysis of sentinel lymph node biopsy in the treatment of early-stage vulvar cancer.

Authors:  Britt K Erickson; Laura M Divine; Charles A Leath; J Michael Straughn
Journal:  Int J Gynecol Cancer       Date:  2014-10       Impact factor: 3.437

8.  Optimization of near-infrared fluorescent sentinel lymph node mapping for vulvar cancer.

Authors:  Merlijn Hutteman; Joost R van der Vorst; Katja N Gaarenstroom; Alexander A W Peters; J Sven D Mieog; Boudewijn E Schaafsma; Clemens W G M Löwik; John V Frangioni; Cornelis J H van de Velde; Alexander L Vahrmeijer
Journal:  Am J Obstet Gynecol       Date:  2011-07-30       Impact factor: 8.661

9.  Use of the Sentinel Lymph Node Technique Compared to Complete Inguino-femoral Lymph Node Removal in Patients with Invasive Vulvar Cancer in Germany.

Authors:  F Kramer; H Hertel; P Hillemanns
Journal:  Geburtshilfe Frauenheilkd       Date:  2013-02       Impact factor: 2.915

10.  Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance.

Authors:  Floris P R Verbeek; Quirijn R J G Tummers; Daphne D D Rietbergen; Alexander A W Peters; Boudewijn E Schaafsma; Cornelis J H van de Velde; John V Frangioni; Fijs W B van Leeuwen; Katja N Gaarenstroom; Alexander L Vahrmeijer
Journal:  Int J Gynecol Cancer       Date:  2015-07       Impact factor: 3.437

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.